ORIC

Oric Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 6/10
  • Momentum↑ 7/10
Oric Pharmaceuticals sales and earnings growth
ORIC Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 19.67%
  • FCF Y/Y↓ 1.90%
Oric Pharmaceuticals gross and profit margin trends
ORIC Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -45.70%
Oric Pharmaceuticals net debt vs free cash flow
ORIC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Oric Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗